
Surgery Partners (SGRY) Stock Forecast & Price Target
Surgery Partners (SGRY) Analyst Ratings
Bulls say
Surgery Partners is well-positioned for future growth with their integrated outpatient care model and recent divestiture that will improve their cash conversion and reduce leverage. The company's focus on high-acuity procedures and their track record of successful physician recruitment further supports their growth potential. While there are risks in the healthcare industry such as labor shortages and reimbursement challenges, Surgery Partners has a solid financial foundation and significant upside potential.
Bears say
Surgery Partners is facing multiple risks, including its high leverage and potential wage inflation due to competition for clinical labor. In addition, the company may not meet investor expectations for volume and revenue growth, and a potential recession could negatively impact its business. The recent divestiture of its Idaho Falls facilities may improve its margin profile, but the transaction is still pending approval. The company has shown strong share gain and has potential for margin expansion, but its margins may still fall below peers due to its lower exposure to higher-margin ASCs. Given these factors, our outlook on the company's stock is negative.
This aggregate rating is based on analysts' research of Surgery Partners and is not a guaranteed prediction by Public.com or investment advice.
Surgery Partners (SGRY) Analyst Forecast & Price Prediction
Start investing in Surgery Partners (SGRY)
Order type
Buy in
Order amount
Est. shares
0 shares